Skip to main content
Home
  • Main Menu
  • Topics
    • Video
    • Provider
    • Payer
    • Pharma
    • Consumer
    • Investor

Regions

  • ANZ
  • ASIA
  • EMEA
  • Global Edition

ZappRx gets $25M for specialty drug prescribing app

By Heather Mack
April 20, 2017
02:36 pm
Share

Digital specialty prescribing platform ZappRx has raised $25 million in Series B funding in a round led by Qiming US Healthcare Fund. GV, formerly Google Ventures, and SR One also contributed funding.

ZappRx’s cloud-based platform serves as a conduit for providers, pharmacies and patients to collaborate on the prescribing and management of specialty medications, which are used for complex illnesses ranging from cancer to neurological conditions. To relieve the multi-step, manual and fragmented processes traditionally used – which result in information siloes and data backlogs – the ZappRx app works to streamlines communication between doctor, pharmacy and patient, and it also helps users manage health insurance and payment information.

The added capital will be used to expand ZappRx’s workforce as the company explores greater adoption from providers and other partners. There are a number of prescription apps out there with a large footprint (including Digital Pharmacist, which recently acquired PocketRX to serve some 6,000 pharmacists around the country), but ZappRx is banking on the increasingly valuable specialty drug industry to keep it competitive. In the past five years, the $100 billion market for specialty drugs has nearly doubled and is projected to reach $400 billion by 2020. 

"We are excited to have top tier investors, Qiming US, SR One, and GV stand behind our product and our vision to transform specialty drug prescribing," ZappRx Founder and CEO Zoë Barry said in a statement.

What’s more, the app also captures large amounts of rich, real-time data that could provide valuable insights to specialty biopharma companies. This potential to leverage this longitudinal and disease area is a key attraction to investors.

"ZappRx has created a unified platform that we believe will dramatically transform the ecosystem experience around specialty drugs to benefit providers, payers, pharmacists, patients, and biopharma manufacturers," Quiming US Managing Partner, Mark McDade, said in a statement. 

Tags: 
ZappRx, Qiming US Healthcare Fund, GV, Google Ventures, SR One, e-prescribing platform, pharmacy app, specialty pharmacy, pharma

More regional news

Pharmacist interacting online

Serve You Rx, Amazon Pharmacy partner for home delivery

By
Anthony Vecchione
May 02, 2025
Two people shaking hands with six others watch

DarioHealth closes up to $50M debt refinancing and more funding news

By
Jessica Hagen
May 02, 2025
Smart phone and smart watch

Oura and Google Fitbit partner with academia and others to battle opioid disorder

By
Anthony Vecchione
May 02, 2025
Share

Top Story

Smart phone and smart watch
Oura and Google Fitbit partner with academia and others to battle opioid disorder

Editor's Pick

23andMe files for bankruptcy, CEO Wojcicki resigns
Q&A: Oura appoints its first chief medical officer
First blood pressure management system integrated with DeepSeek in Hong Kong
Emirates will offer inflight telemedicine aboard 300 aircraft
Nanowear announces partnership with Dexcom
Navina raises $55M to expand AI for value-based care

More Stories

Pharmacist interacting online
Serve You Rx, Amazon Pharmacy partner for home delivery
Two people shaking hands with six others watch
DarioHealth closes up to $50M debt refinancing and more funding news
Nurse consulting with patient
Teton unveils 3D hospital digital twin using Denmark's supercomputer
Young person communicating with a cell phone
Talkspace, Bark Technologies partner to monitor children's online activities
Pharmacist giving a person an injection
Plenful scores $50M and more funding news
Person interacting with a healthcare professional via tablet
Teladoc acquires UpLift for $30M, releases first quarter results
Person in a pharmacy setting
Hims & Hers, Novo Nordisk partner to offer weight-loss drug Wegovy
Healthcare professional looking at a PC screen
Commure, HealthTap partner for expanded after-hours care
Home

More News

  • Healthcare IT News
  • Healthcare IT News Australia
  • Healthcare Finance News
  • HIMSS TV

MobiHealthNews

 

Connect

Add MobiHealthNews to your network.
HIMSS25 European Health Conference & Exhibition
HIMSS25 European Health Conference & Exhibition
Get ready for knowledge-sharing, all the latest innovations, and in-depth demos with Europe's most influential healthcare community.
10 - 12 June, 2025 | Paris
Learn More
AI in Healthcare Forum
AI in Healthcare Forum
The HIMSS AI in Healthcare Forum cuts through the hype to showcase real-world examples illustrating the transformative potential, and realistic challenges of AI application across the care continuum.
10 - 11 July 2025 | New York
Learn More

Footer Menu

  • About
  • Advertise
  • Reprints
  • Contact
  • Privacy Policy

© 2025 MobiHealthNews is a publication of HIMSS Media

X

Topics

  • Video
  • Provider
  • Payer
  • Pharma
  • Consumer
  • Investor

Career

  • Events
  • Jobs
  • Learning Center

More

  • About
  • Advertise
  • Contact
  • Privacy Policy

Regions

  • ANZ
  • ASIA
  • EMEA
  • Global Edition

MobiHealthNews:

The latest news in digital health delivered daily to your inbox.

Search form

Top Stories

Smart phone and smart watch
Oura and Google Fitbit partner with academia and others to battle opioid disorder
Three surgeons operating on a patient
Thyroid cancer AI assistant developed in Hong Kong
A doctor discussing findings with an older patient
Digital dementia support project gets $2M federal funding and more briefs